Outset is a pioneering medical technology company that puts the patient before the machine. Our human-centered model is designed to dramatically improve not only the care experience – for patients, families, providers and physicians alike – but also cost-efficiency of dialysis delivery. We believe in introducing technology innovation in order to drive service model innovation. And in doing so, we intend to profoundly and permanently impact when, where and who can dialyze.
Outset Medical’s Tablo Hemodialysis System is CE-marked and has been cleared by the U.S. Food and Drug Administration (FDA) for use in acute and chronic care settings. Through design simplicity, wireless medical informatics and a novel integrated, on-demand water purification system, Tablo is essentially a dialysis clinic on wheels that delivers easier, lower cost dialysis. A U.S. clinical trial is underway to enable the use of Tablo at home.